Medicare Enrolled

Dr. Ann Anderson, MD

Clinical Pathology/Laboratory Medicine Physician · Garden City, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
700 STEWART AVE STE 101, Garden City, NY 11530
5162807930
In practice since 2006 (19 years)
NPI: 1154492247 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Anderson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Anderson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Anderson

Dr. Ann Anderson is a clinical pathology/laboratory medicine physician in Garden City, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Anderson performed 109,251 Medicare services across 26,508 unique beneficiaries.

Between the years covered by Open Payments, Dr. Anderson received a total of $181 from 6 pharmaceutical and/or device companies across 6 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in clinical pathology/laboratory medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Anderson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 2% volume in NY $181 industry payments

Medicare Practice Summary

Medicare Utilization ↗
109,251
Medicare services
Top 2% in NY for clinical pathology/laboratory medicine physician
26,508
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5,750 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Infectious disease DNA/RNA test
A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism.
43,807 $34 $105
Genetic analysis to identify organisms
A laboratory test that uses genetic analysis and an amplified probe technique to identify specific organisms.
40,237 $34 $105
Molecular pathology test interpretation
A physician reviews and interprets the results of a molecular pathology test to provide a diagnostic report.
3,917 $40 $159
TB DNA amplification test
A laboratory test that uses DNA amplification to detect the presence of tuberculosis bacteria in a sample.
3,354 $41 $125
Staphylococcus aureus DNA test
A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample.
3,354 $34 $105
Strep A nucleic acid amplification test
A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present.
3,354 $34 $105
Yeast/candida DNA test
A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample.
3,353 $34 $105
Group B Strep DNA test
A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria.
3,353 $34 $105
VRE nucleic acid detection test
A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample.
3,352 $34 $105
PALB2 gene full sequence analysis
A genetic test that examines the complete sequence of the PALB2 gene to identify mutations. This analysis helps determine if there are changes in the DNA that may affect cancer risk.
554 $663 $2,030
BRCA1 and BRCA2 gene analysis
A genetic test that examines the full sequence of the BRCA1 and BRCA2 genes to detect duplication or deletion variants.
543 $1,788 $5,475
Manual urine cell examination
A laboratory test where a technician manually examines a urine sample under a microscope to identify and count cells.
18 $584 $2,130
MLH1 gene full sequence analysis
A laboratory test that examines the complete DNA sequence of the MLH1 gene to identify mutations associated with hereditary nonpolyposis colon cancer.
11 $662 $2,026
MUTYH gene full sequence analysis
A genetic test that examines the complete sequence of the MUTYH gene to identify mutations associated with nonpolyposis colon cancer.
11 $374 $1,145
Full sequence analysis of MSH6 gene
A genetic test that examines the complete sequence of the MSH6 gene to identify any mutations or variations.
11 $629 $1,926
Gene analysis, full sequence
A laboratory test that determines the complete DNA sequence of a specific gene. This analysis identifies variations in the genetic code to assess biological characteristics.
11 $663 $2,030
Molecular pathology procedure level 9
A high-complexity molecular pathology test involving advanced genetic or genomic analysis. This level indicates the most complex type of molecular diagnostic procedure performed.
11 $1,960 $6,000
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$181
Total received (2018-2024)
Avg $45/year across 4 years
Top 39% in NY for clinical pathology/laboratory medicine physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
6
Companies
6
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$181 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$74
2023
$25
2019
$15
2018
$68

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Illumina, Inc.
$27
Myriad Genetic Laboratories, Inc.
$24
Roche Diagnostics Corporation
$22
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$68
Illumina, Inc.
$27
IBSA Pharma Inc.
$25
Myriad Genetic Laboratories, Inc.
$24
Roche Diagnostics Corporation
$22
Genentech USA, Inc.
$15
Top 3 companies account for 66.3% of all-time payments
Associated products mentioned in payments ›
LICART · Oncology Testing · PROLARIS · VIRTUOSO System for IHC
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a clinical pathology/laboratory medicine physician in Garden City?
Compare clinical pathology/laboratory medicine physicians in the Garden City area by procedure volume, costs, and industry payment transparency.
Browse clinical pathology/laboratory medicine physicians nearby

Geographic Context

Clinical pathology/laboratory medicine physicians within 10 mi
55
Per 100K population
4.0
County median income
$143,408
Nearest hospital
LONG ISLAND JEWISH MEDICAL CENTER
2.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Anderson is a mixed practice specialist, with above-average Medicare volume (top 2% in NY), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Anderson experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Anderson performed 43,807 infectious disease dna/rna test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Anderson receive payments from pharmaceutical companies?
Yes. Dr. Anderson received a total of $181 from 6 companies across 6 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Anderson's costs compare to other clinical pathology/laboratory medicine physicians in Garden City?
Dr. Anderson's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Anderson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →